Deal Announcements

Theraclone Sciences Raises New Venture Capital

Tuesday, March 23, 2010 5:51:00 AM PDT | VentureDeal Staff

Seattle, Washington  --  Biotechnology company Theraclone Sciences has secured $1.5 million in an early round of institutional venture capital funding.

Theraclone says that it is developing discovery stage therapeutic antibodies for the treatment of infectious diseases and inflammation.

Investors in the round were not disclosed, nor was how the company intends to use the funding proceeds.

Email Page  Email Page | Print Page Print Page

Free Trial

Want unlimited access to the complete database with thousands of technology companies, VCs and transactions for only $25 per month?

Start your Free 14 Day Trial now – no obligation or credit card required.

Free 14 day trial. No Obligation. Click to Register.
Venturedeal Twitter Venturedeal Facebook Venturedeal Linkedin

PCI - Level1